Iowa Administrative Code › Agency 657 - Pharmacy Board › Chapter 10 - Controlled Substances › Rule 657-10.24 - Prescription Requirements

Current through Register Vol. 47, No. 3, July 24, 2024
All prescriptions for controlled substances shall be dated as
				of, and signed on, the day issued. Controlled substances prescriptions shall be
				valid for six months following date of issue. A prescription for a Schedule
				III, IV, or V controlled substance may include authorization to refill the
				prescription no more than five times within the six months following date of
				issue. A prescription for a Schedule II controlled substance shall not be
				refilled. Beginning January 1, 2020, all prescriptions for controlled
				substances shall be transmitted electronically to a pharmacy pursuant to rule
				657-21.6(124,155A), except as provided in rule
				657-21.8 (124,155A).
(1)
Form of prescription.
All prescriptions for controlled substances shall bear the full name and
			 address of the patient; the drug name, strength, dosage form, quantity
			 prescribed, and directions for use; and the name, address, and DEA registration
			 number of the prescriber. All prescriptions for controlled substances issued by
			 individual prescribers shall include the legibly preprinted, typed, or
			 hand-printed name of the prescriber as well as the prescriber's written or
			 electronic signature. A prescription for a controlled substance issued prior to
			 January 1, 2020, or a prescription for a controlled substance that is exempt
			 from the electronic prescription mandate pursuant to rule
			 657-21.8 (124,155A), may be
			 transmitted via nonelectronic methods as described in this rule.
a. When an oral order is not permitted, or
			 when a prescriber is unable to prepare and transmit an electronic prescription
			 in compliance with DEA requirements for electronic prescriptions, prescriptions
			 shall be written with ink, indelible pencil, or typed print and shall be
			 manually signed by the prescriber. If the prescriber utilizes an electronic
			 prescription application that meets DEA requirements for electronic
			 prescriptions, the prescriber may electronically prepare and transmit a
			 prescription for a controlled substance to a pharmacy that utilizes a pharmacy
			 prescription application that meets DEA requirements for electronic
			 prescriptions.
b. A prescriber's
			 agent may prepare a prescription for the review, authorization, and manual or
			 electronic signature of the prescriber, but the prescribing practitioner is
			 responsible for the accuracy, completeness, and validity of the
			 prescription.
c. An electronic
			 prescription for a controlled substance shall not be transmitted to a pharmacy
			 except by the prescriber in compliance with DEA regulations.
d. A prescriber shall securely maintain the
			 unique authentication credentials issued to the prescriber for utilization of
			 the electronic prescription application and authentication of the prescriber's
			 electronic signature. Unique authentication credentials issued to any
			 individual shall not be shared with or disclosed to any other prescriber,
			 agent, or individual.
e. A
			 corresponding liability rests upon the pharmacist who fills a prescription not
			 prepared in the form prescribed by this rule.